congressional research service enforcement of hem 2

Congressional Research Service: Enforcement of Hemp Ban ‘Remains Unclear’

HempBanking #SAFEBanking #FinancialAccess #HempIndustry #PaymentProcessing #CannabisBanking #BankingCrisis #HempBusiness #CreditCards #SmallBusiness
Why This Matters
The cannabis enforcement paradox, extended to hemp:
🌿 Marijuana: federally illegal, states do what they want
🌿 Hemp (post-Nov): same thing?
CRS: ‘The federal response has largely been to allow states to implement their own marijuana laws despite the fact that state-regulated activities may violate the CSA.’
Will hemp follow the same path? The uncertainty is the cruelest part. ⚖️
#FederalEnforcement #HempBan #CannabisLaw #StateVsFederal

Overview

A CRS analysis suggests the FDA and DEA ‘may lack the resources to broadly enforce’ the new hemp prohibitions. If intoxicating hemp products persist after Nov 2026, they could face the same issues as marijuana: banking restrictions, interstate commerce limits, and federal prosecution exposure—though the likelihood remains uncertain. The parallel to state-legal cannabis is striking: despite Schedule I status, federal response has largely been to allow states to implement their own laws.

Dr. Caplan’s Take
“No bank account = no business. It’s that simple. 🏦
The hemp banking crisis timeline:
2018-2025: Difficult but manageable
2025-2026: Processors pulling back
Post-November 2026: Potential banking desert
Without the SAFE Banking Act:
❌ No credit card processing
❌ No business checking accounts
❌ No payroll services
❌ No SBA loans
This is the quiet killer of hemp businesses. #HempIndustry #Banking #SAFE”

Clinical Perspective

THE ENFORCEMENT PARADOX: WILL THE HEMP BAN FOLLOW MARIJUANA’S PATH?

A Congressional Research Service analysis published in December raised a question the hemp industry has been whispering about for months: will the ban actually be enforced?

The CRS report suggests that both the FDA and DEA ‘may lack the resources to broadly enforce the new prohibitions.’ It draws a direct parallel to the wider cannabis industry, noting that despite marijuana remaining federally illegal as a Schedule I substance, ‘the federal response has largely been to allow states to implement their own marijuana laws despite the fact that state-regulated activities may violate the Controlled Substances Act.’

If intoxicating hemp products persist after November 2026, they could face the same consequences as marijuana: banking restrictions, interstate commerce limitations, and theoretical federal prosecution exposure—though the likelihood of broad enforcement remains uncertain.

This creates a strange kind of regulatory purgatory. Products that are illegal on paper may continue to exist in practice, particularly in states that have their own hemp regulatory frameworks. The uncertainty itself becomes a form of regulation—driving compliant businesses out while leaving less scrupulous operators in the market.

The irony is profound: the same enforcement gap that allowed the hemp market to grow uncontrolled may now preserve it, albeit in diminished and legally precarious form.

Source: https://businessofcannabis.com/us-hemp-industry-in-limbo-as-fda-deadline-for-cannabinoid-definitions-arrives/

You cannot copy content of this page